| Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma M Esteller, G Gaidano, SN Goodman, V Zagonel, D Capello, B Botto, ... Journal of the National Cancer Institute 94 (1), 26-32, 2002 | 364 | 2002 |
| Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP P Pregno, A Chiappella, M Bellò, B Botto, S Ferrero, S Franceschetti, ... Blood, The Journal of the American Society of Hematology 119 (9), 2066-2073, 2012 | 293 | 2012 |
| Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia D Capello, U Vitolo, L Pasqualucci, S Quattrone, G Migliaretti, L Fassone, ... Blood, The Journal of the American Society of Hematology 95 (2), 651-659, 2000 | 263 | 2000 |
| 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow … F Morschhauser, J Radford, A Van Hoof, B Botto, AZS Rohatiner, G Salles, ... Journal of Clinical Oncology 31 (16), 1977-1983, 2013 | 241 | 2013 |
| Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial U Vitolo, A Chiappella, S Franceschetti, AM Carella, I Baldi, G Inghirami, ... The Lancet Oncology 15 (7), 730-737, 2014 | 211 | 2014 |
| Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma L Ceriani, M Martelli, PL Zinzani, AJM Ferreri, B Botto, C Stelitano, M Gotti, ... Blood, The Journal of the American Society of Hematology 126 (8), 950-956, 2015 | 182 | 2015 |
| Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi F Merli, S Luminari, A Tucci, A Arcari, L Rigacci, E Hawkes, CS Chiattone, ... Journal of clinical oncology 39 (11), 1214-1222, 2021 | 131 | 2021 |
| Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients U Vitolo, G Gaidano, B Botto, G Volpe, E Audisio, M Bertini, R Calvi, ... Annals of oncology 9 (1), 55-61, 1998 | 121 | 1998 |
| Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination G Benevolo, A Stacchini, M Spina, AJM Ferreri, M Arras, L Bellio, B Botto, ... Blood, The Journal of the American Society of Hematology 120 (16), 3222-3228, 2012 | 105 | 2012 |
| Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials PL Zinzani, S Viviani, A Anastasia, U Vitolo, S Luminari, F Zaja, ... haematologica 98 (8), 1232, 2013 | 97 | 2013 |
| Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a … U Vitolo, A Chiappella, E Angelucci, G Rossi, AM Liberati, MG Cabras, ... haematologica 94 (9), 1250, 2009 | 95 | 2009 |
| MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single … AJM Ferreri, JK Doorduijn, A Re, MG Cabras, J Smith, F Ilariucci, M Luppi, ... The Lancet Haematology 8 (2), e110-e121, 2021 | 85 | 2021 |
| Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse … U Vitolo, S Cortellazzo, AM Liberati, R Freilone, M Falda, M Bertini, ... Journal of clinical oncology 15 (2), 491-498, 1997 | 79 | 1997 |
| The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen M Bertini, R Freilone, U Vitolo, B Botto, R Ciottp, S Cinieri, AD Nota, ... Leukemia & lymphoma 22 (5-6), 483-493, 1996 | 75 | 1996 |
| P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL) M Bertini, R Freilone, U Vitolo, B Botto, M Pizzuti, P Gavarotti, A Levis, ... Annals of oncology 5 (10), 895-900, 1994 | 73 | 1994 |
| Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients PL Zinzani, G Rossi, S Franceschetti, B Botto, A Di Rocco, MG Cabras, ... Clinical Cancer Research 16 (15), 3998-4004, 2010 | 71 | 2010 |
| Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced … U Vitolo, M Ladetto, C Boccomini, L Baldini, F De Angelis, A Tucci, B Botto, ... Journal of clinical oncology 31 (27), 3351-3359, 2013 | 70 | 2013 |
| Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma AR Filippi, P Ciammella, C Piva, R Ragona, B Botto, P Gavarotti, F Merli, ... International Journal of Radiation Oncology* Biology* Physics 89 (2), 370-375, 2014 | 51 | 2014 |
| Molecular heterogeneity of B‐lineage diffuse large cell lymphoma G Volpe, U Vitolo, A Carbone, C Pastore, M Bertini, B Botto, E Audisio, ... Genes, Chromosomes and Cancer 16 (1), 21-30, 1996 | 50 | 1996 |
| Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy AR Filippi, A Botticella, M Bellò, B Botto, A Castiglione, P Gavarotti, ... Leukemia & lymphoma 54 (6), 1183-1187, 2013 | 48 | 2013 |
